Home › Glioblastoma › Kentucky › Lexington
Glioblastoma clinical trials in Lexington, KY
5 studies for Glioblastoma are looking for participants at sites in and around Lexington (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Testing the Addition of an Anti-cancer Drug, Selinexor, to the Usual Chemotherapy Treatment (Temozolomide) for Brain Tumors That Have Returned After Previous Treatment
RecruitingPhase 1/2
- University of Kentucky/Markey Cancer Center, Lexington
Testing the Addition of an Anti-Cancer Drug, Triapine, to the Usual Radiation Therapy for Recurrent Glioblastoma or Astrocytoma
RecruitingPhase 1
- University of Kentucky/Markey Cancer Center, Lexington
SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)
RecruitingPhase 3
- University of Kentucky, Lexington
Safety and Tolerability of ²¹²Pb-DOTAM-GRPR1 in Adult Subjects With Recurrent or Metastatic GRPR-expressing Tumors
RecruitingPhase 1
- UK Markey Cancer Center, Lexington
Loupe-Based Intraoperative Fluorescence Imaging
RecruitingObservational study
- University of Kentucky, Lexington
Glioblastoma trials in other cities
- New York City, NY30 studies
- Boston, MA28 studies
- Houston, TX26 studies
- Los Angeles, CA24 studies
- Durham, NC20 studies
- San Francisco, CA17 studies
- Chicago, IL15 studies
- Washington, DC15 studies
- Miami, FL14 studies
- Columbus, OH14 studies
- Rochester, MN13 studies
- Jacksonville, FL13 studies
Other studies in Lexington
- Non-Small Cell Lung Cancer23 studies
- Lung Cancer18 studies
- Ovarian Cancer16 studies
- Prostate Cancer14 studies
- Cancer (all types)14 studies
- Breast Cancer14 studies
- Metastatic Cancer11 studies
- Colorectal Cancer11 studies
- Heart Failure11 studies
- Melanoma10 studies
- Acute Myeloid Leukemia10 studies
- Obesity10 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.